🌐 Geopolitical🇮🇳 India
Trump's 200% Tariff Threat on Generic Drugs Puts Indian Pharma on Alert
The Hindu·Thursday, 23 July 2026
Donald Trump has announced that all generic drugs entering the US will have zero tariffs until August 2028, after which they rise to 100% for one year, then jump to 200%. Indian pharma companies have warned this would seriously endanger Americans who depend on affordable generic medicines. The ultimatum is essentially: make your drugs in the US, or pay up.
Why It Matters
India is one of the world's largest suppliers of generic medicines to the US — this tariff threat could hit Indian pharmaceutical companies hard and affect jobs across the sector.
🔒 Potential Impact + source link
Subscribe to unlock the impact analysis and original source for every story.